American Society of Hirudotherapy

Non-Occlusive Mesenteric Ischemia Due to Hirudotherapy: A Case Report

Case report published in Cureus (2020)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Clinical TrialsDrug DevelopmentSafety & Infection ControlAkalın Ç, Ekmen N · Cureus, 2020

Summary

Leech therapy, which can lead to complications such as anemia and bleeding, has been used to treat many diseases since ancient times. Furthermore, some substances in leech saliva are known to have anticoagulant effects.

Why This Matters for Hirudotherapy

Contributes clinical evidence for the therapeutic application of leech therapy.

Citation

Non-Occlusive Mesenteric Ischemia Due to Hirudotherapy: A Case Report.

Akalın Ç, Ekmen N · Cureus, 2020

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.